Latest / Stock Movers / WPP Gains, GSK Falls, Monte Paschi Up
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The.
- 0:08Speaker 2: Stock Movers Report, your roundup of companies making moves in
- 0:12Speaker 2: the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 3: Let's take a look at some of the socks on
- 0:17Speaker 3: the mood today here in Europe. I'm Caroline Hepcat alongside
- 0:20Speaker 3: Stephen Caroll. We're joined by Bloomberg reporter Cloe Lay. Now
- 0:23Speaker 3: let's start with WPP rising this morning. What is driving
- 0:27Speaker 3: the change then for the advertising company, it's.
- 0:30Speaker 1: Because they just got a by rating at Berenberg and
- 0:33Speaker 1: and this is saying that essentially the fears around AI
- 0:36Speaker 1: are very much overdone, and they said that the entire
- 0:39Speaker 1: advertising sector actually will remain relevant in the age of AI,
- 0:43Speaker 1: and that this technology will actually more likely strengthen rather
- 0:47Speaker 1: than weaken them. And the analysts from Bhrenberg actually upgraded
- 0:51Speaker 1: all three of those big list of names in Europe
- 0:53Speaker 1: and advertising, so that's Publicists, have As and WPP. But
- 0:57Speaker 1: the reason why we saw WPP jump in particular was
- 1:01Speaker 1: because sentiment has been very negative around that company. So
- 1:04Speaker 1: this BI rating is seen as actually quite a big relief.
- 1:08Speaker 1: You know, It's worth noting that the shares are still
- 1:10Speaker 1: down about nineteen percent this year for WPP. It's been
- 1:13Speaker 1: having a tough time for quite a while. Now it's
- 1:16Speaker 1: in the middle of this quite complicated turnaround where it's reorganizing,
- 1:19Speaker 1: rearranging a lot of the internal structure, it's cutting down
- 1:23Speaker 1: a lot of those costs, and it still has lost
- 1:26Speaker 1: quite a lot of clients recently to publicists in particular,
- 1:29Speaker 1: that's really the biggest rival, and that's a rival that's
- 1:32Speaker 1: been also doing very very well. So it's still dealing
- 1:34Speaker 1: with all of those challenges. Those are still relevant, but
- 1:37Speaker 1: at least from an air perspective, it should be fine,
- 1:40Speaker 1: is essentially what Brenberg are saying.
- 1:43Speaker 3: Okay, Sotart's on WPP, turning next to some m and
- 1:47Speaker 3: A news from GSK.
- 1:50Speaker 1: Yeah, big m ANDA news for JSK this morning is
- 1:52Speaker 1: buying a US biotech company called New Valent for ten
- 1:55Speaker 1: point six billion dollars, So really big, big MNA this morning.
- 1:59Speaker 1: That is going to really help GSK broaden its cancer portfolio.
- 2:03Speaker 1: So that's been a real focus for GSK recently. It
- 2:06Speaker 1: had actually sold its cancer portfolio to Nevatis about ten
- 2:11Speaker 1: years ago, but now it's really trying to get back
- 2:14Speaker 1: on that. On that oncologies in that oncology space and
- 2:17Speaker 1: make progress there under the new CEO and New Zealand
- 2:21Speaker 1: is a step towards that, so it develops therapies for
- 2:24Speaker 1: lung cancer as specifically, and a couple of the drugs
- 2:27Speaker 1: that are in development are in late stage trials, could
- 2:30Speaker 1: get regulatory approval very soon and have the potential to
- 2:33Speaker 1: become blogbuster medicines once approved, So that's going to be
- 2:37Speaker 1: probably very beneficial for JESK. It all seems very exciting.
- 2:41Speaker 1: But the shares are down slightly this morning, as always
- 2:44Speaker 1: with those M and A stories usually that is because
- 2:46Speaker 1: the price tag is looking maybe a little bit steep,
- 2:49Speaker 1: and Bloomberg at Tangents did say that the price leaves
- 2:52Speaker 1: a little room for missteps, so that's something to keep
- 2:54Speaker 1: in mind. But it's probably going to be a boost
- 2:57Speaker 1: for JSK down the line.
- 2:58Speaker 3: Yeah, Okay, that's fuss TSK now still a big story though.
- 3:04Speaker 3: The very popular MONSTEPASKI how are they doing after news
- 3:08Speaker 3: of buyer interests yesterday?
- 3:10Speaker 1: Yeah? I think this Italian banking saga is going to
- 3:13Speaker 1: be something we talk about for quite a while. So
- 3:16Speaker 1: all of the names involved in this in somewhere we're
- 3:19Speaker 1: in the green this morning, so we had a Monte Depasci,
- 3:21Speaker 1: which is of course the target of all of this
- 3:24Speaker 1: takeover interest up this morning. Then we had both of
- 3:27Speaker 1: the suitors to Bank of PPM and in tessin Sampaolo
- 3:30Speaker 1: also in the green. And then also Uniporn, which is
- 3:32Speaker 1: the insurance company that would have a part to play
- 3:35Speaker 1: in this deal if in Tessa actually went out, so
- 3:40Speaker 1: that company also up very strongly. And so meanwhile the
- 3:43Speaker 1: background to this that we've got the Italian government saying
- 3:46Speaker 1: that they will not be getting involved, will not interfere
- 3:48Speaker 1: in this, and said that ultimately whoever pays more is
- 3:51Speaker 1: going to determine whether Bank of BPM or in Tessa
- 3:54Speaker 1: went out. Right now, the latest is that Montetepski is
- 3:58Speaker 1: assessing both bids. So we are still waiting for further developments.
- 4:03Speaker 1: Will we see higher offers, will we see anyone backing down.
- 4:06Speaker 1: Everything is still very much in play, so I'm sure
- 4:08Speaker 1: that we'll be back talking about this very soon.
- 4:11Speaker 2: The Stock Movers Report from Bloomberg Radio. Check back with
- 4:15Speaker 2: us throughout the day for the latest roundup of companies
- 4:18Speaker 2: making news on Wall Street and for the latest market
- 4:21Speaker 2: moving headlines. Listen to Bloomberg Radio Live. Catch us on YouTube,
- 4:25Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 4:29Speaker 2: the Bloomberg Business app.